Literature DB >> 15248100

Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).

S Rudnik-Schöneborn1, P Stolz, R Varon, K Grohmann, M Schächtele, U-P Ketelsen, D Stavrou, H Kurz, C Hübner, K Zerres.   

Abstract

We describe 6 unrelated patients affected by infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) with prolonged survival upon mechanical ventilation (4.5-11 years), which has not been reported before. Biallelic mutations in the IGHMBP2 gene proved the diagnosis of SMARD1 in all patients. Disease onset was in the first 2 months in the described patients, starting with generalised hypotonia, failure to thrive, and early breathing difficulties. Diaphragmatic palsy was diagnosed and permanent ventilation was initiated 2-8 months after onset. Within months a more distal muscular atrophy became evident associated with joint contractures (talipes), hand drops, and fatty finger pads. Motor development remained minimal, loss of function was observed within the first year after which no further progression was recorded. Voiding dysfunction with reflux nephropathy was observed in 3 patients and has not been reported before. Further evidence of autonomic nerve dysfunction resulting in cardiac arrhythmia, hypertension, and excessive sweating was given in 2 patients. Investigative results were largely compatible with those obtained in classic SMA. However, neurogenic atrophy muscle was more pronounced in distal muscles, if examined, and there was evidence of peripheral nerve involvement at least in some patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15248100     DOI: 10.1055/s-2004-820994

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  18 in total

1.  Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man.

Authors:  Tyler Mark Pierson; Gary Tart; David Adams; Camilo Toro; Gretchen Golas; Cynthia Tifft; William Gahl
Journal:  Neuromuscul Disord       Date:  2011-02-25       Impact factor: 4.296

2.  Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival.

Authors:  Terry P Maddatu; Sean M Garvey; David G Schroeder; Wiedong Zhang; Soh-Yule Kim; Anthony I Nicholson; Crystal J Davis; Gregory A Cox
Journal:  Hum Mol Genet       Date:  2005-09-20       Impact factor: 6.150

3.  Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd.

Authors:  Monir Shababi; Caley E Smith; Mona Kacher; Zayd Alrawi; Eric Villalón; Daniel Davis; Elizabeth C Bryda; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2019-10-08       Impact factor: 3.575

Review 4.  Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1.

Authors:  Alberto Giannini; Anna Maria Pinto; Giordano Rossetti; Edi Prandi; Danilo Tiziano; Christina Brahe; Nardo Nardocci
Journal:  Intensive Care Med       Date:  2006-09-09       Impact factor: 17.440

5.  Distal Spinal Muscular Atrophy: An Overlooked Etiology of Weaning Failure in Children with Respiratory Insufficiency.

Authors:  Mojdeh Habibi Zoham; Asgar Eghbalkhah; Kamyar Kamrani; Nahid Khosroshahi; Hossein Yousefimanesh; Zahra Eskandarizadeh
Journal:  J Pediatr Intensive Care       Date:  2018-01-04

6.  Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.

Authors:  Monir Shababi; Zhihua Feng; Eric Villalon; Christine M Sibigtroth; Erkan Y Osman; Madeline R Miller; Patricka A Williams-Simon; Abby Lombardi; Thalia H Sass; Arleigh K Atkinson; Michael L Garcia; Chien-Ping Ko; Christian L Lorson
Journal:  Mol Ther       Date:  2016-02-10       Impact factor: 11.454

7.  Clinical diversity caused by novel IGHMBP2 variants.

Authors:  Jun-Hui Yuan; Akihiro Hashiguchi; Akiko Yoshimura; Hiroshi Yaguchi; Koji Tsuzaki; Azusa Ikeda; Kenji Wada-Isoe; Masahiro Ando; Tomonori Nakamura; Yujiro Higuchi; Yu Hiramatsu; Yuji Okamoto; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2017-03-09       Impact factor: 3.172

8.  Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.

Authors:  Christopher R Heier; Rosalba Satta; Cathleen Lutz; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2010-08-06       Impact factor: 6.150

9.  Vascular perfusion abnormalities in infants with spinal muscular atrophy.

Authors:  Alexandra prufer de Queiroz Campos Araujo; Mario Araujo; Kathryn J Swoboda
Journal:  J Pediatr       Date:  2009-08       Impact factor: 4.406

Review 10.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.